
Global Health (MEDANTA) | Stock Overview & Key Data
Global Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,513.90 on February 12, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Global Health MEDANTA | 350.74B Large-cap | -1.21% | -6.55% | 13.31% | 5.97% | 18.52% | 34.90% | 215.01% | 215.01% |
Max Healthcare MAXHEALTH | 1.09T Large-cap | -1.76% | -5.76% | -13.01% | 2.73% | -2.32% | 20.17% | 167.60% | 905.60% |
Apollo Hospitals APOLLOHOSP | 1.08T Large-cap | -2.65% | -3.00% | -0.73% | 12.19% | 0.97% | 9.85% | 69.34% | 226.78% |
Fortis Healthcare FORTIS | 740.99B Large-cap | 3.05% | 7.03% | 27.74% | 43.71% | 39.68% | 70.22% | 259.61% | 640.76% |
Narayana Hrudayalaya NH | 358.59B Large-cap | -2.70% | -2.94% | -16.80% | 5.84% | 31.43% | 43.24% | 139.60% | 396.26% |
Aster DM Healthcare ASTERDM | 341.80B Large-cap | -0.28% | 4.24% | 6.98% | 31.55% | 21.14% | 52.95% | 152.80% | 357.47% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MEDANTA's 52-week high and low?
- In the last 52 weeks, Global Health reached a high of ₹1,456.50 (on August 8, 2025) and a low of ₹935.50 (on October 7, 2024).
- What is the market cap and P/E ratio for MEDANTA?
- Curious about Global Health's size and valuation? Its market capitalization stands at 350.74B. When it comes to valuation, the P/E ratio (trailing twelve months) is 65.34, and the forward P/E (looking ahead) is 56.13.
- Does MEDANTA pay dividends? If so, what's the yield?
- Yes, Global Health is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.04%, and the company has paid an average of ₹0.17 per share annually over the past 3 years.
- Who are Global Health's main competitors or similar companies to consider before investing?
When looking at Global Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.09T Healthcare Medical Care Facilities 20.17% 167.60% Apollo Hospitals
APOLLOHOSP1.08T Healthcare Medical Care Facilities 9.85% 69.34% Fortis Healthcare
FORTIS740.99B Healthcare Medical Care Facilities 70.22% 259.61% Narayana Hrudayalaya
NH358.59B Healthcare Medical Care Facilities 43.24% 139.60% Aster DM Healthcare
ASTERDM341.80B Healthcare Medical Care Facilities 52.95% 152.80% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Global Health Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Global Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.21%, the Debt to Equity ratio from the most recent quarter is 21.19, and its Gross Profit Margin stands at 76.81%.
- What is the recent revenue and earnings growth for MEDANTA?
- Looking at Global Health's growth, its revenue over the trailing twelve months (TTM) was INR39B. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.70%, and quarterly earnings saw a YoY growth of 49.60%.
- How much of MEDANTA stock is held by insiders and institutions?
- Wondering who owns Global Health stock? Company insiders (like executives and directors) hold about 67.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 20.91%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.